Targeted nanocarriers for imaging and therapy of vascular inflammation

Current Opinion in Colloid and Interface Science

Volumn 16, Issue 3, 2011, Pages 215-227

  Chacko, Ann Marie ^a   Hood, Elizabeth D ^a   Zern, Blaine J ^a   Muzykantov, Vladimir R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell adhesion molecule; Drug delivery; Inflammation; Molecular imaging; Nanomedicine; Nanoparticles

Indexed keywords

ADHESION MOLECULES; ANIMAL STUDIES; ANTI-INFLAMMATORY AGENTS; ANTI-PROLIFERATIVE; CELL ADHESION MOLECULES; COMPLEX MECHANISMS; DRUG DELIVERY SYSTEM; HUMAN STUDY; IMAGE-GUIDED; IMAGING MODALITY; IMAGING PROBE; INFLAMMATION; ISCHEMIA REPERFUSION; MOLECULAR IMAGING; NANOCARRIERS; NANOMEDICINES; NANOPARTICLE PROBES; OPTICAL IMAGING MODALITIES; RESTENOSIS;

ADHESION; ANIMALS; CELL ADHESION; DISEASE CONTROL; DISEASES; DRUG DELIVERY; ENDOTHELIAL CELLS; ENZYME INHIBITION; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; PATHOLOGY; PROBES;

MAGNETIC RESONANCE IMAGING;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; CD31 ANTIGEN; CELL ADHESION MOLECULE; COPPER 64; DENDRIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUORINE 18; FLUOROCARBON; GADOLINIUM; INDIUM 111; INTERCELLULAR ADHESION MOLECULE 1; IODINE 123; IODINE 124; IRON OXIDE; NANOCARRIER; NANOPARTICLE; PADGEM PROTEIN; QUANTUM DOT; TECHNETIUM 99M; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

CELL ACTIVATION; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; FLUORESCENCE IMAGING; NANOMEDICINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOACTIVITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ULTRASOUND; VASCULITIS;

EID: 79955978835     PISSN: 13590294     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cocis.2011.01.008     Document Type: Review

References (93)

1. Muzykantov V.R. Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 2001, 71:1-21.
2. Simone E., Ding B.S., Muzykantov V. Targeted delivery of therapeutics to endothelium. Cell Tissue Res 2009, 335:283-300.
3. Christofidou-Solomidou M., Muzykantov V.R. Antioxidant strategies in respiratory medicine. Treat Respir Med 2006, 5:47-78.
4. Muro S., Muzykantov V.R. Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr Pharm Des 2005, 11:2383-2401.
5. Kluger M.S. Vascular endothelial cell adhesion and signaling during leukocyte recruitment. Adv Dermatol 2004, 20:163-201.
6. Almenar-Queralt A., Duperray A., Miles L.A., Felez J., Altieri D.C. Apical topography and modulation of ICAM-1 expression on activated endothelium. Am J Pathol 1995, 147:1278-1288.
7. Ding B.S., Dziubla T., Shuvaev V.V., Muro S., Muzykantov V.R. Advanced drug delivery systems that target the vascular endothelium. Mol Interv 2006, 6:98-112.
8. Dobrucki L.W., Sinusas A.J. PET and SPECT in cardiovascular molecular imaging. Nat Rev 2010, 7:38-47.
9. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
10. Ahren M., Selegard L., Klasson A., Soderlind F., Abrikossova N., Skoglund C., et al. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. Langmuir 2010, 26:5753-5762.
11. Weissleder R., Stark D.D., Engelstad B.L., Bacon B.R., Compton C.C., White D.L., et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989, 152:167-173.
12. Penfield J.G., Reilly R.F. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 2007, 3:654-668.
13. Caruthers S.D., Neubauer A.M., Hockett F.D., Lamerichs R., Winter P.M., Scott M.J., et al. In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Invest Radiol 2006, 41:305-312.
14. Neubauer A.M., Caruthers S.D., Hockett F.D., Cyrus T., Robertson J.D., Allen J.S., et al. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. J Cardiovasc Magn Reson 2007, 9:565-573.
15. 1H MRI are described for the first time.
16. 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Magn Reson Med 2008, 60:1066-1072.
17. Tran T.D., Caruthers S.D., Hughes M., Marsh J.N., Cyrus T., Winter P.M., et al. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomedicine 2007, 2:515-526.
18. Villanueva F.S. Molecular imaging of cardiovascular disease using ultrasound. J Nucl Cardiol 2008, 15:576-586.
19. Sinusas A.J., Bengel F., Nahrendorf M., Epstein F.H., Wu J.C., Villanueva F.S., et al. Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging 2008, 1:244-256.
20. Marsh J.N., Partlow K.C., Abendschein D.R., Scott M.J., Lanza G.M., Wickline S.A. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound Med Biol 2007, 33:950-958.
21. Hughes M.S., Marsh J.N., Hall C.S., Fuhrhop R.W., Lacy E.K., Lanza G.M., et al. Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging. J Acoust Soc Am 2005, 117:964-972.
22. Lanza G.M., Wallace K.D., Scott M.J., Cacheris W.P., Abendschein D.R., Christy D.H., et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996, 94:3334-3340.
23. Weissleder R., Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003, 9:123-128.
24. Hueber A.J., Stevenson R., Stokes R.J., Graham D., Garside P., McInnes I.B. Imaging inflammation in real time-future of nanoparticles. Autoimmunity 2009, 42:368-372.
25. Gioux S., Choi H.S., Frangioni J.V. Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 2010, 9:237-255.
26. Judenhofer M.S., Wehrl H.F., Newport D.F., Catana C., Siegel S.B., Becker M., et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 2008, 14:459-465.
27. 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug Chem 2008, 19:1496-1504.
28. Oostendorp M., Douma K., Wagenaar A., Slenter J.M., Hackeng T.M., van Zandvoort M.A., et al. Molecular magnetic resonance imaging of myocardial angiogenesis after acute myocardial infarction. Circulation 2010, 121:775-783.
29. Nahrendorf M., Zhang H., Hembrador S., Panizzi P., Sosnovik D.E., Aikawa E., et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008, 117:379-387.
30. Dziubla T.D., Shuvaev V.V., Hong N.K., Hawkins B.J., Madesh M., Takano H., et al. Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. Biomaterials 2008, 29:215-227.
31. Kobayashi H., Brechbiel M.W. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 2005, 57:2271-2286.
32. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
33. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007, 2:249-255.
34. Gratton S.E., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008, 105:11613-11618.
35. Sharma G., Valenta D.T., Altman Y., Harvey S., Xie H., Mitragotri S., et al. Polymer particle shape independently influences binding and internalization by macrophages. J Control Release 2010, 147:408-412.
36. Muro S., Garnacho C., Champion J.A., Leferovich J., Gajewski C., Schuchman E.H., et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 2008, 16:1450-1458.
37. Torchilin V.P. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006, 58:1532-1555.
38. Otsuka H., Nagasaki Y., Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 2003, 55:403-419.
39. Fukukawa K., Rossin R., Hagooly A., Pressly E.D., Hunt J.N., Messmore B.W., et al. Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. Biomacromolecules 2008, 9:1329-1339.
40. Anderson C.J., Bulte J.W., Chen K., Chen X., Khaw B.A., Shokeen M., et al. Design of targeted cardiovascular molecular imaging probes. J Nucl Med 2010, 51(Suppl 1):3S-17S.
41. Chen W., Jarzyna P.A., van Tilborg G.A.F., Nguyen V.A., Cormode D.P., Klink A., et al. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J 2010, 24:1689-1699.
42. Uppal R., Caravan P. Targeted probes for cardiovascular MR imaging. Future Med Chem 2010, 2:451-470.
43. Nobs L., Buchegger F., Gurny R., Allemann E. Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci 2004, 93:1980-1992.
44. Moghimi S.M., Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003, 42:463-478.
45. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
46. Buchanan K.D., Huang S., Kim H., Macdonald R.C., McPherson D.D. Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. J Pharm Sci 2008, 97:2242-2249.
47. Hamilton A.J., Huang S.L., Warnick D., Rabbat M., Kane B., Nagaraj A., et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol 2004, 43:453-460.
48. Kim H., Moody M.R., Laing S.T., Kee P.H., Huang S.L., Klegerman M.E., et al. In vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes. Invest Radiol 2010, 45:685-691.
49. Kamaly N., Miller A.D. Paramagnetic liposome nanoparticles for cellular and tumour imaging. Int J Mol Sci 2010, 11:1759-1776.
50. Li D., Patel A.R., Klibanov A.L., Kramer C.M., Ruiz M., Kang B.Y., et al. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging 2010, 3:464-472.
51. 18F]FDP). Nucl Med Biol 2007, 34:165-171.
52. Phillips W.T., Goins B.A., Bao A. Radioactive liposomes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:69-83.
53. Christian D.A., Cai S., Bowen D.M., Kim Y., Pajerowski J.D., Discher D.E. Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm 2009, 71:463-474.
54. Dziubla T.D., Karim A., Muzykantov V.R. Polymer nanocarriers protecting active enzyme cargo against proteolysis. J Control Release 2005, 102:427-439.
55. Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
56. Veiseh O., Gunn J.W., Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010, 62:284-304.
57. Weissleder R., Moore A., Mahmood U., Bhorade R., Benveniste H., Chiocca E.A., et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000, 6:351-355.
58. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
59. Yallapu M.M., Foy S.P., Jain T.K., Labhasetwar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res 2010, 27:2283-2295.
60. Chorny M., Hood E., Levy R.J., Muzykantov V.R. Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles. J Control Release 2010, 146:144-151.
61. Hughes M.S., Caruthers S., Tran T.D., Marsh J.N., Wallace K., Cyrus T., et al. Perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Proc IEEE 2008, 96:397-415.
62. Soman N.R., Lanza G.M., Heuser J.M., Schlesinger P.H., Wickline S.A. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. Nano Lett 2008, 8:1131-1136.
63. Kaneda M.M., Caruthers S., Lanza G.M., Wickline S.A. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng 2009, 37:1922-1933.
64. Lee C.C., MacKay J.A., Frechet J.M., Szoka F.C. Designing dendrimers for biological applications. Nat Biotechnol 2005, 23:1517-1526.
65. Parrott M.C., Benhabbour S.R., Saab C., Lemon J.A., Parker S., Valliant J.F., et al. Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers. J Am Chem Soc 2009, 131:2906-2916.
66. Jayagopal A., Russ P.K., Haselton F.R. Surface engineering of quantum dots for in vivo vascular imaging. Bioconjug Chem 2007, 18:1424-1433.
67. Smith A.M., Duan H., Rhyner M.N., Ruan G., Nie S. A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots. Phys Chem Chem Phys 2006, 8:3895-3903.
68. Tsourkas A., Shinde-Patil V.R., Kelly K.A., Patel P., Wolley A., Allport J.R., et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug Chem 2005, 16:576-581.
69. Kelly K.A., Allport J.R., Tsourkas A., Shinde-Patil V.R., Josephson L., Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005, 96:327-336.
70. Nahrendorf M., Jaffer F.A., Kelly K.A., Sosnovik D.E., Aikawa E., Libby P., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114:1504-1511.
71. McAteer M.A., Sibson N.R., von Zur Muhlen C., Schneider J.E., Lowe A.S., Warrick N., et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med 2007, 13:1253-1258.
72. Hoyte L.C., Brooks K.J., Nagel S., Akhtar A., Chen R., Mardiguian S., et al. Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab 2010, 30:1178-1187.
73. 19F NMR of VCAM-1 targeted nanobeacons. Nanomedicine 2009, 5:359-367.
74. Kaufmann B.A., Carr C.L., Belcik J.T., Xie A., Yue Q., Chadderdon S., et al. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol 2010, 30:54-59.
75. 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med 2008, 49:103-111.
76. Danilov S.M., Gavrilyuk V.D., Franke F.E., Pauls K., Harshaw D.W., McDonald T.D., et al. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol 2001, 280:L1335-L1347.
77. Muro S., Dziubla T., Qiu W., Leferovich J., Cui X., Berk E., et al. Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther 2006, 317:1161-1169.
78. Reynolds P.R., Larkman D.J., Haskard D.O., Hajnal J.V., Kennea N.L., George A.J., et al. Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 2006, 241:469-476.
79. Chapon C., Franconi F., Lacoeuille F., Hindre F., Saulnier P., Benoit J.P., et al. Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent. Magma 2009, 22:167-174.
80. van Kasteren S.I., Campbell S.J., Serres S., Anthony D.C., Sibson N.R., Davis B.G. Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci U S A 2009, 106:18-23.
81. Jin A.Y., Tuor U.I., Rushforth D., Filfil R., Kaur J., Ni F., et al. Magnetic resonance molecular imaging of post-stroke neuroinflammation with a P-selectin targeted iron oxide nanoparticle. Contrast Media Mol Imaging 2009, 4:305-311.
82. Buttgereit F., Burmester G.R., Lipworth B.J. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet 2005, 365:801-803.
83. Muzykantov V.R. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium. Expert Opin Drug Deliv 2005, 2:909-926.
84. Carnemolla R., Shuvaev V.V., Muzykantov V.R. Targeting antioxidant and antithrombotic biotherapeutics to endothelium. Semin Thromb Hemost 2010, 36:332-342.
85. Homem de Bittencourt P.I., Lagranha D.J., Maslinkiewicz A., Senna S.M., Tavares A.M., Baldissera L.P., et al. LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions. Atherosclerosis 2007, 193:245-258.
86. Garnacho C., Dhami R., Simone E., Dziubla T., Leferovich J., Schuchman E.H., et al. Delivery of acid sphingomyelinase in normal and niemann-pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J Pharmacol Exp Ther 2008, 325:400-408.
87. Muro S., Gajewski C., Koval M., Muzykantov V.R. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood 2005, 105:650-658.
88. Calderon A.J., Bhowmick T., Leferovich J., Burman B., Pichette B., Muzykantov V., et al. Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J Control Release 2010.
89. Herbst S.M., Klegerman M.E., Kim H., Qi J., Shelat H., Wassler M., et al. Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1. Mol Pharm 2009, 7:3-11.
90. Asgeirsdottir S.A., Zwiers P.J., Morselt H.W., Moorlag H.E., Bakker H.I., Heeringa P., et al. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. Am J Physiol Ren Physiol 2008, 294:F554-F561.
91. Hashida N., Ohguro N., Yamazaki N., Arakawa Y., Oiki E., Mashimo H., et al. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome. Exp Eye Res 2008, 86:138-149.
92. Ferrante E.A., Pickard J.E., Rychak J., Klibanov A., Ley K. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 2009, 140:100-107.
93. Weller G.E., Villanueva F.S., Tom E.M., Wagner W.R. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng 2005, 92:780-788.